The Epstein-Barr Virus BART miRNA Cluster of the M81 Strain Modulates Multiple Functions in Primary B Cells

PLoS Pathogens

Volumn 11, Issue 12, 2015, Pages

  Lin, Xiaochen ^a   Tsai, Ming Han ^a   Shumilov, Anatoliy ^a   Poirey, Remy ^a   Bannert, Helmut ^a   Middeldorp, Jaap M ^b   Feederle, Regina ^a,c   Delecluse, Henri Jacques ^a  

^a GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 3; ETOPOSIDE; IMMEDIATE EARLY PROTEIN BZLF1; IONOMYCIN; LATENT MEMBRANE PROTEIN 1; MICRORNA; NERVE GROWTH FACTOR RECEPTOR; OLIGONUCLEOTIDE; RNA INDUCED SILENCING COMPLEX; SIMVASTATIN; STAUROSPORINE; TYPE II SITE SPECIFIC DEOXYRIBONUCLEASE; VIRUS RNA;

ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS ASSAY; ARTICLE; B LYMPHOCYTE; CONTROLLED STUDY; EPSTEIN BARR VIRUS; GENE DELETION; HISTOLOGY; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; LUCIFERASE ASSAY; MOUSE; NEWBORN; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; TUMOR GROWTH; TUMOR VOLUME; VIRUS INDUCTION; WESTERN BLOTTING; ANIMAL; EPSTEIN BARR VIRUS INFECTION; GENE EXPRESSION REGULATION; GENETIC TRANSFECTION; GENETICS; REAL TIME POLYMERASE CHAIN REACTION; VIROLOGY; VIRUS CELL TRANSFORMATION; VIRUS GENE; VIRUS REPLICATION;

ANIMALS; B-LYMPHOCYTES; BLOTTING, WESTERN; CELL TRANSFORMATION, VIRAL; EPSTEIN-BARR VIRUS INFECTIONS; GENE EXPRESSION REGULATION, VIRAL; GENES, VIRAL; HERPESVIRUS 4, HUMAN; HUMANS; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MICE; MICRORNAS; REAL-TIME POLYMERASE CHAIN REACTION; RNA, VIRAL; TRANSFECTION; VIRUS REPLICATION;

EID: 84953246290     PISSN: 15537366     EISSN: 15537374     Source Type: Journal    
DOI: 10.1371/journal.ppat.1005344     Document Type: Article

References (50)

1. Kieff ED, Rickinson AB, Knipe DM HP, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, (2007) Epstein-Barr Virus and its replication. In: Field Virology. Philadelphia: Lippincott Williams & Wilkins. pp. 2603–2654.
2. Rickinson AB, Kieff E, Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, (2007) Epstein-Barr virus. In: et al., editors. Fields Virology. 5th Edition ed. Philadelphia: Lippincott Williams & Wilkins. pp. 2655–2700.
3. Pfeffer S, Zavolan M, Grasser FA, Chien M, Russo JJ, et al. (2004) Identification of virus-encoded microRNAs. Science 304: 734–736. 15118162
4. Grundhoff A, Sullivan CS, Ganem D, (2006) A combined computational and microarray-based approach identifies novel microRNAs encoded by human gamma-herpesviruses. RNA 12: 733–750. 16540699
5. Cai X, Schafer A, Lu S, Bilello JP, Desrosiers RC, et al. (2006) Epstein-Barr virus microRNAs are evolutionarily conserved and differentially expressed. PLoS Pathog 2: e23. 16557291
6. Seto E, Moosmann A, Gromminger S, Walz N, Grundhoff A, et al. (2010) Micro RNAs of Epstein-Barr virus promote cell cycle progression and prevent apoptosis of primary human B cells. PLoS Pathog 6: e1001063. doi: 10.1371/journal.ppat.1001063 20808852
7. Feederle R, Haar J, Bernhardt K, Linnstaedt SD, Bannert H, et al. (2011) The members of an Epstein-Barr virus microRNA cluster cooperate to transform B lymphocytes. J Virol 85: 9801–9810. doi: 10.1128/JVI.05100-11 21752900
8. Feederle R, Linnstaedt SD, Bannert H, Lips H, Bencun M, et al. (2011) A viral microRNA cluster strongly potentiates the transforming properties of a human herpesvirus. PLoS Pathog 7: e1001294. doi: 10.1371/journal.ppat.1001294 21379335
9. Vereide DT, Seto E, Chiu YF, Hayes M, Tagawa T, et al. (2014) Epstein-Barr virus maintains lymphomas via its miRNAs. Oncogene 33: 1258–1264. doi: 10.1038/onc.2013.71 23503461
10. Qiu J, Cosmopoulos K, Pegtel M, Hopmans E, Murray P, et al. (2011) A novel persistence associated EBV miRNA expression profile is disrupted in neoplasia. PLoS Pathog 7: e1002193. doi: 10.1371/journal.ppat.1002193 21901094
11. Marquitz AR, Raab-Traub N, (2012) The role of miRNAs and EBV BARTs in NPC. Semin Cancer Biol 22: 166–172. doi: 10.1016/j.semcancer.2011.12.001 22178394
12. Hsu CY, Yi YH, Chang KP, Chang YS, Chen SJ, et al. (2014) The Epstein-Barr virus-encoded microRNA MiR-BART9 promotes tumor metastasis by targeting E-cadherin in nasopharyngeal carcinoma. PLoS Pathog 10: e1003974. doi: 10.1371/journal.ppat.1003974 24586173
13. Cai LM, Lyu XM, Luo WR, Cui XF, Ye YF, et al. (2014) EBV-miR-BART7-3p promotes the EMT and metastasis of nasopharyngeal carcinoma cells by suppressing the tumor suppressor PTEN. Oncogene.
14. Lei T, Yuen KS, Xu R, Tsao SW, Chen H, et al. (2013) Targeting of DICE1 tumor suppressor by Epstein-Barr virus-encoded miR-BART3* microRNA in nasopharyngeal carcinoma. Int J Cancer 133: 79–87. doi: 10.1002/ijc.28007 23280823
15. Choy EY, Siu KL, Kok KH, Lung RW, Tsang CM, et al. (2008) An Epstein-Barr virus-encoded microRNA targets PUMA to promote host cell survival. J Exp Med 205: 2551–2560. doi: 10.1084/jem.20072581 18838543
16. Marquitz AR, Mathur A, Nam CS, Raab-Traub N, (2011) The Epstein-Barr Virus BART microRNAs target the pro-apoptotic protein Bim. Virology 412: 392–400. doi: 10.1016/j.virol.2011.01.028 21333317
17. Kang D, Skalsky RL, Cullen BR, (2015) EBV BART MicroRNAs Target Multiple Pro-apoptotic Cellular Genes to Promote Epithelial Cell Survival. PLoS Pathog 11: e1004979. doi: 10.1371/journal.ppat.1004979 26070070
18. Jung YJ, Choi H, Kim H, Lee SK, (2014) MicroRNA miR-BART20-5p stabilizes Epstein-Barr virus latency by directly targeting BZLF1 and BRLF1. J Virol 88: 9027–9037. doi: 10.1128/JVI.00721-14 24899173
19. Iizasa H, Wulff BE, Alla NR, Maragkakis M, Megraw M, et al. (2010) Editing of Epstein-Barr virus-encoded BART6 microRNAs controls their dicer targeting and consequently affects viral latency. J Biol Chem 285: 33358–33370. doi: 10.1074/jbc.M110.138362 20716523
20. Qiu J, Thorley-Lawson DA, (2014) EBV microRNA BART 18-5p targets MAP3K2 to facilitate persistence in vivo by inhibiting viral replication in B cells. Proc Natl Acad Sci U S A 111: 11157–11162. doi: 10.1073/pnas.1406136111 25012295
21. Tsai MH, Raykova A, Klinke O, Bernhardt K, Gartner K, et al. (2013) Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas. Cell Rep 5: 458–470. doi: 10.1016/j.celrep.2013.09.012 24120866
22. Klinke O, Feederle R, Delecluse HJ, (2014) Genetics of Epstein-Barr virus microRNAs. Semin Cancer Biol 26: 52–59. doi: 10.1016/j.semcancer.2014.02.002 24602823
23. Kuzembayeva M, Chiu YF, Sugden B, (2012) Comparing proteomics and RISC immunoprecipitations to identify targets of Epstein-Barr viral miRNAs. PLoS One 7: e47409. doi: 10.1371/journal.pone.0047409 23091622
24. Dolken L, Malterer G, Erhard F, Kothe S, Friedel CC, et al. (2010) Systematic analysis of viral and cellular microRNA targets in cells latently infected with human gamma-herpesviruses by RISC immunoprecipitation assay. Cell Host Microbe 7: 324–334. doi: 10.1016/j.chom.2010.03.008 20413099
25. Skalsky RL, Corcoran DL, Gottwein E, Frank CL, Kang D, et al. (2012) The viral and cellular microRNA targetome in lymphoblastoid cell lines. PLoS Pathog 8: e1002484. doi: 10.1371/journal.ppat.1002484 22291592
26. Barth S, Pfuhl T, Mamiani A, Ehses C, Roemer K, et al. (2008) Epstein-Barr virus-encoded microRNA miR-BART2 down-regulates the viral DNA polymerase BALF5. Nucleic Acids Res 36: 666–675. 18073197
27. Davies ML, Xu S, Lyons-Weiler J, Rosendorff A, Webber SA, et al. (2010) Cellular factors associated with latency and spontaneous Epstein-Barr virus reactivation in B-lymphoblastoid cell lines. Virology 400: 53–67. doi: 10.1016/j.virol.2010.01.002 20153012
28. Michalak EM, Villunger A, Adams JM, Strasser A, (2008) In several cell types tumour suppressor p53 induces apoptosis largely via Puma but Noxa can contribute. Cell Death Differ 15: 1019–1029. doi: 10.1038/cdd.2008.16 18259198
29. Jones RJ, Seaman WT, Feng WH, Barlow E, Dickerson S, et al. (2007) Roles of lytic viral infection and IL-6 in early versus late passage lymphoblastoid cell lines and EBV-associated lymphoproliferative disease. Int J Cancer 121: 1274–1281. 17520680
30. Delecluse HJ, Hilsendegen T, Pich D, Zeidler R, Hammerschmidt W, (1998) Propagation and recovery of intact, infectious Epstein-Barr virus from prokaryotic to human cells. Proc Natl Acad Sci U S A 95: 8245–8250. 9653172
31. Feederle R, Neuhierl B, Bannert H, Geletneky K, Shannon-Lowe C, et al. (2007) Epstein-Barr virus B95.8 produced in 293 cells shows marked tropism for differentiated primary epithelial cells and reveals interindividual variation in susceptibility to viral infection. Int J Cancer 121: 588–594. 17417777
32. Tsang CM, Yip YL, Lo KW, Deng W, To KF, et al. (2012) Cyclin D1 overexpression supports stable EBV infection in nasopharyngeal epithelial cells. Proc Natl Acad Sci U S A 109: E3473–3482. doi: 10.1073/pnas.1202637109 23161911
33. Qiu J, Smith P, Leahy L, Thorley-Lawson DA, (2015) The Epstein-Barr virus encoded BART miRNAs potentiate tumor growth in vivo. PLoS Pathog 11: e1004561. doi: 10.1371/journal.ppat.1004561 25590614
34. Lung RW, Tong JH, Sung YM, Leung PS, Ng DC, et al. (2009) Modulation of LMP2A expression by a newly identified Epstein-Barr virus-encoded microRNA miR-BART22. Neoplasia 11: 1174–1184. 19881953
35. Riley KJ, Rabinowitz GS, Yario TA, Luna JM, Darnell RB, et al. (2012) EBV and human microRNAs co-target oncogenic and apoptotic viral and human genes during latency. EMBO J 31: 2207–2221. doi: 10.1038/emboj.2012.63 22473208
36. Lo AK, To KF, Lo KW, Lung RW, Hui JW, et al. (2007) Modulation of LMP1 protein expression by EBV-encoded microRNAs. Proc Natl Acad Sci U S A 104: 16164–16169. 17911266
37. Le Clorennec C, Youlyouz-Marfak I, Adriaenssens E, Coll J, Bornkamm GW, et al. (2006) EBV latency III immortalization program sensitizes B cells to induction of CD95-mediated apoptosis via LMP1: role of NF-kappaB, STAT1, and p53. Blood 107: 2070–2078. 16317104
38. Pratt ZL, Zhang J, Sugden B, (2012) The latent membrane protein 1 (LMP1) oncogene of Epstein-Barr virus can simultaneously induce and inhibit apoptosis in B cells. J Virol 86: 4380–4393. doi: 10.1128/JVI.06966-11 22318153
39. Li L, Li W, Xiao L, Xu J, Chen X, et al. (2012) Viral oncoprotein LMP1 disrupts p53-induced cell cycle arrest and apoptosis through modulating K63-linked ubiquitination of p53. Cell Cycle 11: 2327–2336. doi: 10.4161/cc.20771 22684299
40. Bissels U, Wild S, Tomiuk S, Holste A, Hafner M, et al. (2009) Absolute quantification of microRNAs by using a universal reference. RNA 15: 2375–2384. doi: 10.1261/rna.1754109 19861428
41. Kanda T, Miyata M, Kano M, Kondo S, Yoshizaki T, et al. (2015) Clustered MicroRNAs of the Epstein-Barr Virus Cooperatively Downregulate an Epithelial Cell-Specific Metastasis Suppressor. J Virol 89: 2684–2697. doi: 10.1128/JVI.03189-14 25520514
42. Graham FL, Smiley J, Russell WC, Nairn R, (1977) Characteristics of a human cell line transformed by DNA from human adenovirus type 5. J Gen Virol 36: 59–74. 886304
43. Shaw G, Morse S, Ararat M, Graham FL, (2002) Preferential transformation of human neuronal cells by human adenoviruses and the origin of HEK 293 cells. Faseb J 16: 869–871. Epub 2002 Apr 2010. 11967234
44. Ben-Bassat H, Goldblum N, Mitrani S, Goldblum T, Yoffey JM, et al. (1977) Establishment in continuous culture of a new type of lymphocyte from a "Burkitt like" malignant lymphoma (line D.G.-75). Int J Cancer 19: 27–33. 188769
45. Feederle R, Bartlett EJ, Delecluse HJ, (2010) Epstein-Barr virus genetics: talking about the BAC generation. Herpesviridae 1(1):6. doi: 10.1186/2042-4280-1-6 21429237
46. Yoshiyama H, Shimizu N, Takada K, (1995) Persistent Epstein-Barr virus infection in a human T-cell line: unique program of latent virus expression. EMBO J 14: 3706–3711. 7641689
47. Kanda T, Yajima M, Ahsan N, Tanaka M, Takada K, (2004) Production of high-titer Epstein-Barr virus recombinants derived from Akata cells by using a bacterial artificial chromosome system. J Virol 78: 7004–7015. 15194777
48. Janz A, Oezel M, Kurzeder C, Mautner J, Pich D, et al. (2000) Infectious Epstein-Barr virus lacking major glycoprotein BLLF1 (gp350/220) demonstrates the existence of additional viral ligands. J Virol 74: 10142–10152. 11024143
49. Griffin BE, Bjorck E, Bjursell G, Lindahl T, (1981) Sequence complexity of circular Epstein-Bar virus DNA in transformed cells. J Virol 40: 11–19. 6270367
50. Feederle R, Neuhierl B, Baldwin G, Bannert H, Hub B, et al. (2006) Epstein-Barr virus BNRF1 protein allows efficient transfer from the endosomal compartment to the nucleus of primary B lymphocytes. J Virol 80: 9435–9443. 16973549